Gary A Lyons's Net Worth
$38.7 Million
Estimate Recalculated Nov 8, 2024 04:32PM EST
Who is Gary A Lyons?
Gary A Lyons has an estimated net worth of $38.7 Million. This is based on reported shares across multiple companies, which include FACET BIOTECH CORP, NEUROCRINE BIOSCIENCES INC, NeurogesX Inc, Travere Therapeutics, Inc., RIGEL PHARMACEUTICALS INC, PONIARD PHARMACEUTICALS, INC., KALOBIOS PHARMACEUTICALS INC, CYTORI THERAPEUTICS, INC., Novus Therapeutics, Inc., VICAL INC, PDL BIOPHARMA, INC., and INTRABIOTICS PHARMACEUTICALS INC /DE.
SEC CIK
Gary A Lyons's CIK is 0001123343
Past Insider Trading and Trends
2020 was Gary A Lyons's most active year for acquiring shares with 21 total transactions. Gary A Lyons's most active month to acquire stocks was the month of April. 2005 was Gary A Lyons's most active year for disposing of shares, totalling 49 transactions. Gary A Lyons's most active month to dispose stocks was the month of October. 2004 saw Gary A Lyons paying a total of $5,971,600.00 for 154,000 shares, this is the most they've acquired in one year. In 2024 Gary A Lyons cashed out on 52,100 shares for a total of $4,109,849.87, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
FACET BIOTECH CORP No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -2.50K |
$27.00 | -$67,500.00 |
0
|
Apr 21
| |||
Form 4
| -76.92% | -8.33K |
$27.00 | -$224,991.00 | 2.5K |
Apr 20
| |||
Form 4
| +30.00% | 2.5K |
—
|
—
| 10.83K |
May 26
| |||
Form 4
|
∞
| 8.33K |
—
|
—
| 8.33K |
Jan 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NEUROCRINE BIOSCIENCES INC (NBIX) Snapshot price: $120.17
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$96.60 | -$1,245,716.45 | 119.05K |
Scheduled
|
Aug 13
| ||
Form 4
|
—
|
0
|
$96.40 | -$99,763.42 | 119.05K |
Scheduled
|
Jul 16
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
| +1.80% | 2.1K |
—
|
—
| 119.05K |
May 17
| |||
Form 4
|
—
|
0
|
$89.20 | -$1,160,870.00 | 116.95K |
Scheduled
|
May 14
| ||
Form 4
| -4.91% | -10.00K |
$130.04 | -$1,300,443.00 | 193.7K |
Scheduled
|
Dec 22
| ||
Form 4
|
—
|
0
|
$64.88 | -$518,937.00 | 203.7K |
Scheduled
|
Dec 1
| ||
Form 4
|
—
|
0
|
$64.00 | -$510,220.00 | 203.7K |
Sep 12
| |||
Form 4
|
—
|
0
|
$61.52 | -$485,415.50 | 203.7K |
Sep 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
|
—
|
0
|
$63.74 | -$1,530,753.00 | 203.7K |
Scheduled
|
Oct 31
| ||
Form 4
| -2.40% | -5.00K |
$110.54 | -$552,711.00 | 203.7K |
Scheduled
|
Oct 4
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
|
—
|
0
|
$49.71 | -$1,291,492.50 | 208.7K |
Scheduled
|
Apr 25
| ||
Form 4
| -2.34% | -5.00K |
$105.06 | -$525,293.50 | 208.7K |
Scheduled
|
Oct 7
| ||
Form 4
| -4.47% | -10.00K |
$100.27 | -$1,002,743.00 | 213.7K |
Scheduled
|
Jun 10
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
| -0.89% | -2.00K |
$120.02 | -$240,046.56 | 223.7K |
Scheduled
|
Jan 25 - Jan 26
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
| -2.17% | -5.00K |
$110.00 | -$550,000.00 | 225.7K |
Scheduled
|
Nov 8
| ||
Form 4
| -2.12% | -5.00K |
$100.22 | -$501,103.50 | 230.7K |
Scheduled
|
Nov 1
| ||
Form 4
| -4.07% | -10.00K |
$92.07 | -$920,686.00 | 235.7K |
Scheduled
|
Jul 30
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
| -5.75% | -15.00K |
$114.41 | -$1,716,213.00 | 245.7K |
Scheduled
|
Nov 2
| ||
Form 4
| -5.44% | -15.00K |
$99.24 | -$1,488,549.00 | 260.7K |
Scheduled
|
Jun 13
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 4
| +5.20% | 13.63K |
$42.14 | $22.13 | 275.7K |
Apr 3
| |||
Form 4
| -1.87% | -5.00K |
$84.67 | -$423,341.00 | 262.07K |
Scheduled
|
Feb 15
| ||
Form 4
| -1.84% | -5.00K |
$83.08 | -$415,380.00 | 267.07K |
Scheduled
|
Feb 5
| ||
Form 4
| -3.55% | -10.00K |
$72.92 | -$729,182.00 | 272.07K |
Scheduled
|
Dec 1
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
| +5.62% | 15K |
$3.40 | $51,000.00 | 282.07K |
Feb 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
| +5.95% | 15K |
$3.07 | $46,050.00 | 267.07K |
May 6
| |||
Form 4
| -5.62% | -15.00K |
$54.89 | -$823,300.00 | 252.07K |
Scheduled
|
Sep 18
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 28
| |||
Form 4
| -10.10% | -30.00K |
$41.53 | -$1,245,900.00 | 267.07K |
Scheduled
|
Mar 24
| ||
Form 4/A
| +2.24% | 6.5K |
$20.29 | $13.32 | 297.07K |
Feb 10
| |||
Form 4
| +2.24% | 6.5K |
$20.29 | $13.32 | 297.07K |
Feb 10
| |||
Form 4
| +2.25% | 6.4K |
$18.57 | $17.24 | 290.56K |
Jan 20
| |||
Form 4
| -6.58% | -20.00K |
$15.66 | -$313,200.00 | 284.16K |
Scheduled
|
Sep 15
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
| +11.62% | 31.67K |
$14.24 | $7.50 | 304.16K |
Mar 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 24
| |||
Form 4/A
| +16.75% | 63.09K |
$7.38 | $465,296.13 | 439.66K |
Apr 26
| |||
Form 4
| +16.75% | 63.09K |
$7.38 | $465,296.13 | 439.66K |
Apr 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 19
| |||
Form 4
| +1.49% | 5.65K |
$61.39 | $346,669.33 | 383.57K |
Dec 19
| |||
Form 4
| -1.17% | -5.00K |
$61.95 | -$309,748.00 | 423.11K |
Dec 5
| |||
Form 4
| -1.15% | -5.00K |
$61.78 | -$308,899.45 | 428.11K |
Nov 22
| |||
Form 4
| -1.14% | -5.00K |
$59.70 | -$298,511.00 | 433.11K |
Nov 18
| |||
Form 4
| -2.23% | -10.00K |
$56.28 | -$562,847.14 | 438.11K |
Nov 2 - Nov 3
| |||
Form 4
| -2.18% | -10.00K |
$51.50 | -$515,000.00 | 448.11K |
Oct 27 - Oct 28
| |||
Form 4
| -2.14% | -10.00K |
$49.00 | -$490,000.00 | 457.85K |
Sep 6 - Sep 7
| |||
Form 4
| -1.06% | -5.00K |
$46.76 | -$233,778.96 | 467.85K |
Aug 18
| |||
Form 4
| -1.05% | -5.00K |
$39.70 | -$198,500.00 | 472.85K |
Jun 15
| |||
Form 4
| +0.90% | 5.64K |
$42.78 | $241,493.10 | 632.37K |
Feb 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 18
| |||
Form 4
|
—
|
0
|
$45.87 |
—
| 1.25M |
Dec 8
| |||
Form 4
| -1.57% | -10.00K |
$51.43 | -$514,288.25 | 626.72K |
Scheduled
|
Jul 1
| ||
Form 4
| -1.55% | -10.00K |
$56.04 | -$560,400.00 | 636.72K |
Scheduled
|
Jun 1
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
| -1.52% | -10.00K |
$62.63 | -$626,250.00 | 646.72K |
Scheduled
|
May 3
| ||
Form 4
| -1.50% | -10.00K |
$58.16 | -$581,600.00 | 656.72K |
Scheduled
|
Apr 1
| ||
Form 4
| -1.48% | -10.00K |
$54.15 | -$541,510.00 | 666.01K |
Scheduled
|
Mar 1
| ||
Form 4
| +0.60% | 4K |
$55.15 | $220,600.00 | 676.01K |
Mar 1
| |||
Form 4
| -1.47% | -10.00K |
$56.62 | -$566,204.21 | 672.01K |
Feb 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 15 - Dec 17
| |||
Form 4
| -1.45% | -10.00K |
$54.98 | -$549,811.00 | 682.01K |
Dec 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NeurogesX Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Travere Therapeutics, Inc. (TVTX) Snapshot price: $10.98
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +14.61% | 6.5K |
—
|
—
| 51K |
May 8
| |||
Form 4
| +11.25% | 4.5K |
—
|
—
| 44.5K |
May 17
| |||
Form 4
| +8.11% | 3K |
—
|
—
| 40K |
May 11
| |||
Form 4
| +8.82% | 3K |
—
|
—
| 37K |
May 14
| |||
Form 4
| +9.68% | 3K |
—
|
—
| 34K |
May 15
| |||
Form 4
| +6.90% | 2K |
—
|
—
| 31K |
May 8
| |||
Form 4
| +9.43% | 2.5K |
—
|
—
| 29K |
May 9
| |||
Form 4
| +10.42% | 2.5K |
—
|
—
| 26.5K |
May 17
| |||
Form 4
| +9.09% | 2K |
—
|
—
| 24K |
May 18
| |||
Form 4
| +10.00% | 2K |
—
|
—
| 22K |
Jun 8
| |||
Form 4
|
∞
| 20K |
—
|
—
| 20K |
Oct 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
RIGEL PHARMACEUTICALS INC (RIGL) Snapshot price: $13.32
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +50.00% | 25K |
—
|
—
| 75K |
May 26
| |||
Form 4
| +100.00% | 25K |
—
|
—
| 50K |
May 20
| |||
Form 4
|
∞
| 25K |
—
|
—
| 25K |
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||